Maarten Boers

Active 1987–2025

189
Papers
54,018
Citations
100
h-index
186
i10-index

Citations

Citations per year for Maarten Boers1961: 1 citations1987: 1 citations1990: 1 citations1992: 1 citations1994: 7 citations1995: 21 citations1996: 16 citations1997: 21 citations1998: 24 citations1999: 66 citations2000: 91 citations2001: 89 citations2002: 137 citations2003: 229 citations2004: 302 citations2005: 311 citations2006: 283 citations2007: 290 citations2008: 298 citations2009: 336 citations2010: 367 citations2011: 395 citations2012: 351 citations2013: 407 citations2014: 489 citations2015: 584 citations2016: 572 citations2017: 657 citations2018: 514 citations2019: 1,623 citations2020: 1,693 citations2021: 1,679 citations2022: 1,302 citations2023: 825 citations2024: 1,229 citations2025: 460 citations2026: 16 citations1962–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown1991: no citations, so this year is not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,726 citing papers, 15.3% of this breakdownUnited Kingdom: 2,575 citing papers, 10.5% of this breakdownNetherlands: 1,857 citing papers, 7.6% of this breakdownCanada: 1,452 citing papers, 5.9% of this breakdownGermany: 1,227 citing papers, 5% of this breakdownAustralia: 1,171 citing papers, 4.8% of this breakdownItaly: 1,042 citing papers, 4.3% of this breakdownChina: 980 citing papers, 4% of this breakdownFrance: 894 citing papers, 3.7% of this breakdownSpain: 756 citing papers, 3.1% of this breakdownSwitzerland: 572 citing papers, 2.3% of this breakdownDenmark: 553 citing papers, 2.3% of this breakdown
0%15.3%Other 31.2%

Fields

  • Medicine77.5%
  • Health Professions3.8%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Decision Sciences2.7%
  • Social Sciences2.5%
  • Immunology and Microbiology2.4%
  • Other7.7%

Topics

  • Rheumatoid Arthritis Research and Therapies11.8%
  • Spondyloarthritis Studies and Treatments4.5%
  • Autoimmune and Inflammatory Disorders Research3.2%
  • Systemic Lupus Erythematosus Research3%
  • Osteoarthritis Treatment and Mechanisms2.8%
  • Musculoskeletal pain and rehabilitation2%
  • Other72.7%

Coauthors

All papers

Open in search
  1. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews

    Authors: , , , , , , , , , - BMC Medical Research Methodology 2007 cited by 4,413

  2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 5,775

  3. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde - Annals of the Rheumatic Diseases 2020 cited by 2,766

  4. COSMIN Risk of Bias tool to assess the quality of studies on reliability or measurement error of outcome measurement instruments: a Delphi study

    Authors: , , , , , , , - BMC Medical Research Methodology 2020 cited by 549

  5. How to select outcome measurement instruments for outcomes included in a “Core Outcome Set” – a practical guideline

    Authors: , , , , , , , - Trials 2016 cited by 1,145

  6. The Delphi List

    Authors: , , , , , , - Journal of Clinical Epidemiology 1998 cited by 2,382

  7. Measurement Properties of Visual Analogue Scale, Numeric Rating Scale, and Pain Severity Subscale of the Brief Pain Inventory in Patients With Low Back Pain: A Systematic Review

    Authors: , , , , , - Journal of Pain 2018 cited by 678

  8. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews

    Authors: , , , , , , , - Journal of Clinical Epidemiology 2009 cited by 1,770

  9. Recruitment and Retention of Older People in Clinical Research: A Systematic Literature Review

    Authors: , , , , - Journal of the American Geriatrics Society 2020 cited by 212

  10. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers - Annals of the Rheumatic Diseases 2011 cited by 1,019

  11. American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

    Authors: , , , , , , , , , , , , , , - Arthritis & Rheumatism 1995 cited by 2,844

  12. Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , E Molenaar, JM van Laar, YPM Ruiterman, AERCH Boonen, AERCH Boonen, M Micaelo, J Costa, M Sieburg, JPL Spoorenberg, U Prothmann, MJ Saavedra, I Silva, MT Nurmohamed, JWG Jacobs, SW Tas, JWJ Bijlsma, R Christensen, YM Smulders, SH Ralston, DMFM van der Heijde, AF Marsman, WF Lems, C Rusthoven, M Bakkers, E Frazão Mateus, G Mendes, C Elling-Audersch, D Borucki, A Celano, P Corduta, O Constantinescu, P Richards, GJ Aanerud - Annals of the Rheumatic Diseases 2022 cited by 161

  13. Developing Core Outcome Measurement Sets for Clinical Trials: OMERACT Filter 2.0

    Authors: , , , , , , , , , , , , , , - Journal of Clinical Epidemiology 2014 cited by 784

  14. Core outcome measurement instruments for clinical trials in nonspecific low back pain

    Authors: , , , , , , , , , , , , , , , , , , - Pain 2017 cited by 473

  15. Differences in descriptions of Kellgren and Lawrence grades of knee osteoarthritis

    Authors: , , - Annals of the Rheumatic Diseases 2008 cited by 347

  16. Core outcome domains for clinical trials in non-specific low back pain

    Authors: , , , , , , , , , , , , , , , , , , - European Spine Journal 2015 cited by 393

  17. The HOME Core outcome set for clinical trials of atopic dermatitis

    Authors: , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2022 cited by 151

  18. The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatism 1993 cited by 1,647

  19. The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Rheumatology 2019 cited by 190

  20. Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Seminars in Arthritis and Rheumatism 2013 cited by 320

  21. Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

    Authors: , , , , - Annals of the Rheumatic Diseases 2009 cited by 173

  22. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 331

  23. Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial

    Authors: , , , , , , , , , , , - RMD Open 2021 cited by 72

  24. It's Good to Feel Better But It's Better To Feel Good and Even Better to Feel Good as Soon as Possible for as Long as Possible. Response Criteria and the Importance of Change at OMERACT 10: Figure 1.

    Authors: , , , , , , - The Journal of Rheumatology 2011 cited by 158